HIV-1 readily mutates to escape the immune response, evolving in ways that allow it to persist in the host. New findings reveal that HIV-1 protects itself from antibodies by putting up a shield of constantly shifting sugar moieties. This shield may be contributing to the poor performance of candidate HIV-1 vaccines.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Defining the filarial N-glycoproteome by glycosite mapping in the human parasitic nematode Brugia malayi
Scientific Reports Open Access 16 May 2023
-
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
Scientific Reports Open Access 04 October 2017
-
Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site
Retrovirology Open Access 23 April 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Kimberly Homer
References
Letvin, N.L., Barouch, D.H. & Montefiori, D.C. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu. Rev. Immunol. 20, 73–99 (2002).
Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307–312 (2003).
Wyatt, R. & Sodroski, J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884–1888 (1998).
Albert, J. et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4, 107–112 (1990).
Narayan, O., Griffin, D.E. & Chase, J. Antigenic shift of visna virus in persistently infected sheep. Science 197, 376–378 (1977).
Howe, L., Leroux, C., Issel, C.J. & Montelaro, R.C. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 76, 10588–10597 (2002).
Burns, D.P., Collignon, C. & Desrosiers, R.C. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67, 4104–4113 (1993).
Kwong, P.D. et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678–682 (2002).
Kolchinsky, P., Kiprilov, E. & Sodroski, J. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J. Virol. 75, 2041–2050 (2001).
Montefiori, D.C. et al. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1 infected individual. J. Immunol. (in the press).
Richman, D.D., Wrin, T.L., Little, S.J. & Petropoulos, C.J. Rapid evolution of the neutralizing antibody response to HIV-1 infection. Proc. Natl. Acad. Sci. USA (in the press).
Wrin, T. et al. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquir. Immune. Defic. Syndr. 7, 211–219 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mascola, J., Montefiori, D. HIV-1: nature's master of disguise. Nat Med 9, 393–394 (2003). https://doi.org/10.1038/nm0403-393
Issue date:
DOI: https://doi.org/10.1038/nm0403-393
This article is cited by
-
Defining the filarial N-glycoproteome by glycosite mapping in the human parasitic nematode Brugia malayi
Scientific Reports (2023)
-
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
Scientific Reports (2017)
-
N-glycoprotein macroheterogeneity: biological implications and proteomic characterization
Glycoconjugate Journal (2016)
-
Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site
Retrovirology (2014)
-
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodyteschimpanzee with AIDS related symptoms
Retrovirology (2011)